Skip to main content
Midas Edge

BOSTON SCIENTIFIC CORP

For the period ended Mar 31, 2026. Filed May 1, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 1, 2026

BSX$44.02+3.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

ITEM 6. Exhibits

2.1Agreement and Plan of Merger, dated as of January 14, 2026, among the Company, Pinehurst Merger Sub, Inc. and Penumbra, Inc. (incorporated herein by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K filed on January 15, 2026, File No. 1-11083).
10.1Credit Agreement, dated as of February 26, 2026, by and among Boston Scientific Corporation, the lenders parties thereto and Wells Fargo Bank, National Association, as Administrative Agent, (incorporated herein by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on February 26, 2026. File No. 1-11083).
10.2Credit Agreement, dated as of February 26, 2026, by and among Boston Scientific Corporation, the lenders party thereto and Wells Fargo Bank, National Association, as Administrative Agent, (incorporated herein by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 26, 2026. File No. 1-11083).
10.3Term Loan Credit Agreement, dated as of February 26, 2026, by and among Boston Scientific Corporation, the lenders party thereto and Wells Fargo Bank, National Association, as Administrative Agent., (incorporated herein by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K filed on February 26, 2026. File No. 1-11083).
22Subsidiary Issuer of Guaranteed Securities (incorporated herein by reference to Exhibit 22 to the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, filed on August 1, 2025, File No. 1-11083).
31.1*Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.SCH*Inline XBRL Taxonomy Extension Schema Document.
101.CAL*Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101).
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.